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A B S T R A C T
Aggregation-prone proteins (APPs) have been implicated in numerous human diseases but the underlying me-
chanisms are incompletely understood. Here we comparatively analysed cellular responses to different APPs.
Our study is based on a systematic proteomic and phosphoproteomic analysis of a set of yeast proteotoxicity
models expressing different human disease-related APPs, which accumulate intracellular APP inclusions and
exhibit impaired growth. Clustering and functional enrichment analyses of quantitative proteome-level data
reveal that the cellular response to APP expression, including the chaperone response, is specific to the APP, and
largely differs from the response to a more generalized proteotoxic insult such as heat shock. We further observe
an intriguing association between the subcellular location of inclusions and the location of the cellular response,
and provide a rich dataset for future mechanistic studies. Our data suggest that care should be taken when
designing research models to study intracellular aggregation, since the cellular response depends markedly on
the specific APP and the location of inclusions. Further, therapeutic approaches aimed at boosting protein
quality control in protein aggregation diseases should be tailored to the subcellular location affected by inclusion
formation.
Significance: We have examined the global cellular response, in terms of protein abundance and phosphorylation
changes, to the expression of five human neurodegeneration-associated, aggregation-prone proteins (APPs) in a
set of isogenic yeast models. Our results show that the cellular response to each APP is unique to that protein, is
different from the response to thermal stress, and is associated with processes at the subcellular location of APP
inclusion formation. These results further our understanding of how cells, in a model organism, respond to
expression of APPs implicated in neurodegenerative diseases like Parkinson's, Alzheimer's, and ALS. They have
implications for mechanisms of toxicity as well as of protective responses in the cell. The specificity of the
response to each APP means that research models of these diseases should be tailored to the APP in question. The
subcellular localization of the response suggest that therapeutic interventions should also be targeted within the
cell.
1. Introduction
Protein aggregation diseases, including several neurodegenerative
diseases, are associated with the accumulation of specific protein ag-
gregates in cells and tissues. The proteinaceous components of the
aggregates differ depending on the disease. For example, αSynuclein
(αSyn)-containing aggregates (also called Lewy bodies) are typical of
Parkinsonism. Proteins with lengthened polyglutamine (polyQ) stret-
ches characterize polyQ disorders; an example is huntingtin (HTT),
which is implicated in Huntington's disease. TAR DNA-binding protein
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(TDP43) and fused in sarcoma (FUS) inclusions are observed in patients
with amyotrophic lateral sclerosis. Aggregates of the amyloid-β peptide
(Aβ42) and the protein Tau accumulate in brains of patients with
Alzheimer's disease. The actual effectors of toxicity can be either the
aberrant conformations of the protein, the aggregates or inclusions, the
aggregation process itself, or oligomeric intermediates. Different pa-
thogenic mechanisms have been proposed including membrane da-
mage, saturation of quality control systems, co-sequestration of cyto-
protective factors, and direct damage of specific functional modules
[1–6].
Disease-related aggregation-prone proteins (APPs) differ in primary
sequence and three-dimensional structure, but the physico-chemical
features of mature aggregates, termed amyloid aggregates, are con-
served irrespective of the protein they contain. Amyloids are un-
branched fibrillary structures with a repeating unit consisting of β
strands that run perpendicular to the fiber axis, forming a cross-β sheet
of variable length. In electron micrographs, amyloids appear as long,
nonbranched filaments with diameters of 6–12 nm [7]. Amyloids from
different proteins share features such as protease resistance, insolubility
in detergents, and capability to bind hydrophobic dyes such as thio-
flavin T and Congo Red.
APPs form inclusions in a variety of cell types and model organisms
[8–13]. The appearance of intracellular foci is accompanied by dose-
and time-dependent cytotoxicity, and mutations that increase the pro-
pensity of the APP to aggregate also increase toxicity [14,15], thus
supporting the hypothesis of a toxic gain of function upon aggregation.
Genetic screens have identified genes that significantly reduce or en-
hance cytoxicity of individual APPs [14,16–23]; some of these genes
affect the predisposition for the respective human disease [22,23]. In-
triguingly, genetic interactors of different APPs show only partial
overlap suggesting that different APPs act through different in-
tracellular mechanisms.
Overall, these data raise two questions: 1. Is the cellular response to
protein aggregates specific to the protein that aggregates or can a
generic response to APP aggregates be identified? 2. When aggregates
of a single protein form, is the cellular response similar to when global
protein misfolding is induced, for example by thermal stress?
To determine whether there is a generalized response to APPs, we
comparatively analysed the responses of cells to different APPs using a
well-characterized set of yeast models of APP toxicity. In these models,
different APPs are expressed in Saccharomyces cerevisiae under control
of the same promoter and form intracellular inclusions. As controls for
the effects of generalized protein aggregation and of protein over-
expression we used cells subjected to thermal shock and cells expressing
a protein that does not form aggregates, respectively. To identify
pathways that respond to the aggregation process, we performed phe-
notypic analyses, proteomic and phosphoproteomic measurements. Our
data indicate that there is no generalized response to protein aggrega-
tion, but that the response depends on the aggregating protein, and
suggest that APPs trigger specific compartmentalised responses de-
pendent on the subcellular location of the inclusions.
2. Results
2.1. Phenotypic analysis of cells that express amyloidogenic proteins
To investigate how eukaryotic cells respond to intracellular ag-
gregates of different disease-related APPs, we exploited a set of yeast
strains that individually express five APPs involved in human diseases:
αSyn, FUS, HTT, TDP43, and Aβ42 (Fig. 1, panel a and supplementary
discussion). These proteotoxicity models are directly comparable be-
cause the different APPs are expressed under control of the same (ga-
lactose-inducible) promoter and in the same genetic background (S.
cerevisiae W303). Previous studies showed that expression of these APPs
results in the formation of intracellular inclusions that are toxic to yeast
cells with mechanisms relevant to human disease [19][14,17,20,24–31]
(and supplementary discussion). As a control, we used a yeast strain
transformed with an empty vector (EV). To evaluate the generic re-
sponses of yeast to protein overexpression, we used a yeast strain that
expresses the green fluorescent protein (GFP) under control of the same
promoter used to express the APPs. Further, we compared the responses
of yeast strains to aggregates of specific APPs to those of yeast cells
undergoing generalized protein aggregation induced by heat shock, a
condition known to trigger intracellular aggregation of various proteins
and induction of protein quality control systems [32,33].
To confirm that expression of the five human APPs resulted in cel-
lular toxicity in yeast, we measured the growth of the yeast expressing
each of the APPs and the controls and performed spot assays on in-
ductive (galactose containing) and non-inductive (glucose-containing)
solid media. Growth was severely impaired by the expression of all the
APPs relative to the control and the GFP-expressing strains (Fig. 1,
panel c). The most pronounced effect was observed for the αSyn-ex-
pressing strain, for which a substantial reduction in biomass con-
centration was also observed relative to the control (Fig. 1, panel d). We
confirmed the formation of intracellular inclusions by fluorescence
microscopy using GFP-tagged αSyn, TDP43, and HTT and YFP-tagged
FUS. In each case, we detected the formation of multiple GFP- or YFP-
positive cytoplasmic inclusions between 30 min and 1 h after induction
of expression (Fig. 1, panel b). In the strain expressing GFP alone, a
homogeneous cytoplasmic distribution of the fluorescent signal was
observed. Formation of intracellular inclusions by Aβ42 was previously
shown to be inhibited when the peptide was fused with GFP. Therefore,
formation of Aβ42 intracellular inclusions was confirmed by immuno-
fluorescence as previously reported [24]. Aβ42 inclusions were loca-
lized in both the cytosol and the endoplasmic reticulum (ER) (Fig. 1,
panel b). These data demonstrate that, in our models, expression of the
different APPs results in the formation of intracellular inclusions and is
toxic to yeast cells. The extent of toxicity depends on the expressed APP.
Expression of GFP alone is not toxic to yeast.
2.2. APP aggregation results in widespread alterations in protein abundance
and phosphorylation
To investigate the responses of cells to the formation of intracellular
inclusions of different APPs, we analysed the proteomes and phospho-
proteomes of the APP-expressing and control strains using mass spec-
trometry-based label-free shotgun proteomics. Protein abundance
changes are influenced by transcriptional and translational responses
and protein degradation events. Monitoring changes in the phospho-
proteome provides an additional layer of information regarding reg-
ulatory and signalling events [34].
First, we profiled proteome changes in yeast cells expressing the
different APPs relative to cells expressing the EV at 6, 12, 18, and 24 h
after induction of expression. We obtained relative abundance mea-
surements for 4345 proteins (Table 1). The number of significantly
down-regulated proteins (q-value cutoff: 0.05, fold-change cutoff: −2)
ranged from 166 for the GFP-expressing strain to 1073 for the FUS-
expressing cells. The number of significantly up-regulated proteins (q-
value cutoff: 0.05, fold-change cutoff: 2) ranged from 83 for the GFP-
expressing strain to 395 for the cells that expressed αSyn (Table 2). The
fraction of proteins that changed abundance (out of all detected pro-
teins) increased over time in cells expressing each of the APPs (Fig. 2,
panel a), from 4.9% at 6 h to 20.6% at 24 h for the Aβ42 model, from
1.5% at 6 h to 15.3% at 24 h for the TDP43 model, from 4.7% at 6 h to
32.5% at 24 h for the FUS model and from 0.3% at 6 h to 8.8% at 24 h
for the GFP-expressing strain (Fig. 2, panel a). In both the αSyn and
HTT models, only a small fraction of the proteome had changed
abundance at 6 h (0.7% and 0.5%, respectively); however, after 12 h
12.7% and 6.2% of the measured proteins differed in abundance from
the pre-induction time point, and these numbers remained approxi-
mately constant at 18 and 24 h (Fig. 2, panel a). Interestingly, the
fraction of down-regulated proteins was higher than the fraction of up-
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regulated proteins in most cases, with 26% of the total number of
identified proteins down-regulated in the FUS-expressing strain. The
exception was the αSyn model in which the number of up-regulated
proteins exceeded the number of down-regulated proteins by
approximately 50% (Fig. 2, panel a).
Next, we analysed the phosphoproteomes at 6 h after induction of
expression of the APPs. We identified a total of 3137 phosphosites
across all conditions mapping to 1157 proteins (Table 3 and
Fig. 1. Yeast models of proteotoxicity to analyse the cellular response to aggregation prone proteins (APPs). (a) The schematic shows our experimental design. We
perform quantitative proteomics and phosphoproteomics on yeast strains expressing one of the five indicated APPs and use functional enrichment analysis to identify
altered biological processes. (b) Representative fluorescence micrographs of the indicated yeast strains 1 h after induction of APP expression. In all APP-expressing
strains other than the Aβ42 strain, the micrograph shows GFP fused to the APP. In the Aβ42 strain, the micrograph shows immunofluorescence staining of Aβ42. The
control panel (GFP) shows fluorescence of GFP alone. Scale bars represent 10 μm. (c) Growth curves of the indicated yeast strains over time, after induction of the
APP. Biomass is measured via scattered light upon excitation at 620 nm. NTU, nephelometric turbidity unit. EV, empty vector. (d) Growth on solid media of the
indicated yeast strains under decreasing concentrations of galactose (inducer) and glucose (non-inducer).
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Supplementary Figure 1). In agreement with results at the protein level,
the sample showing the highest number of differentially regulated
phosphosites (q-value cutoff: 0.05, fold change cutoff: 2) was the FUS-
expressing strain (1498 phosphosites). Significantly fewer regulated
phosphosites were detected in cells expressing the other APPs: 19 for
Aβ42, 277 for αSyn, 36 for HTT, and two for TDP43. We detected no
differentially regulated phosphosites in the GFP-expressing control
strain. The temporal trend of protein abundance variations indicates a
progressive alteration of cell homeostasis as a consequence of the ex-
pression of the different APPs. Notably, the expression of GFP also
significantly affected the expression of a small fraction of the proteome
(4%), suggesting that this perturbation is not neutral.
2.3. Proteome responses are APP specific
We analysed the specificity of cellular responses to expression of
different APPs and the similarity to responses of cells undergoing
generalized protein aggregation. As a model for global and nonspecific
protein aggregation, we analysed yeast cells subjected to heat shock.
Heat-shock was previously shown to result in formation of intracellular
protein aggregates involving a large fraction of the proteome [35]. We
incubated wild-type yeast cells for 30 and 60 min at 42 °C, followed by
a recovery phase of 2 h at 30 °C. We performed quantitative proteomics
and phosphoproteomics analyses and quantified a total of 3042 proteins
across the different conditions (Table 2), relative to cells grown at
30 °C. In cells heat shocked for 30 min, 27.8% of the proteome changed
abundance compared to the control; 667 proteins were down-regulated
and 177 up-regulated. After 1 h, levels of 20.7% of the measured pro-
teins were altered; levels of 465 proteins were decreased, and levels of
164 proteins were increased. After the recovery phase, only 0.3% of the
proteome varied in abundance, reflecting restoration of protein home-
ostasis upon return to the optimal growth temperature (Fig. 2, panel a).
We then compared the responses of heat-stressed cells to cells ex-
pressing individual APPs. Hierarchical clustering of protein abundance
Fig. 2. The cellular response to APP expression is largely specific to the aggregating protein. (a) The fraction of proteins that change abundance in the yeast strains at
the indicated times after induction. HS indicates wild type yeast subject to heat shock at 42 °C for 30 or 60 min, with or without a 2 h recovery period at 30 °C. For
APP and GFP strains, we measured abundance relative to the EV-containing yeast. For the HS experiment, we measured abundance relative to yeast grown at 30 °C.
(b) The heat map (left) shows hierarchical clustering of protein abundance changes across time points and conditions. Coloured scale bar represents relative protein
abundances. The right panel shows functional categories enriched for changing proteins in the indicated strains. Cellular component classes are shown. The sig-
nificance level of a category is indicated by the adjusted p-value, the range of which is reported in the colour scale bar. (c) Pairwise comparison of proteins that
change abundance between the indicated strains; the number of changing proteins is shown for each comparison. The bar plot (left) shows the total number of
changing proteins for each strain relative to control. Heat maps (right) show proteins that change in all APP strains (aggregation signature) and in all experimental
strains (overexpression signature). (d) Protein abundance changes of chaperones in the indicated APP strains and in wild type yeast after heat shock, clustered
according to cellular locations.
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changes across all the conditions and time points revealed the presence
of condition-specific signatures (Fig. 2, panel b). The three samples
from the heat shock treatment (30 min, 1 h, and after recovery) formed
a distinct cluster (Fig. 2, panel b - cluster cutoff 0.5) mainly char-
acterized by down-regulated proteins. This possibly reflects the reduc-
tion in protein synthesis and increase in protein degradation that
characterizes the heat-shock response [36,37]. A second cluster in-
cluded the αSyn (12, 18, and 24 h) and HTT (12 and 18 h) models. For
both Aβ42 and the FUS models we observed separate clusters, each
including almost all the time points. Only the 18-h and 24-h time points
for the GFP and HTT models were joined into clusters, indicating the
activation of specific signatures of protein expression in the late stages
of the responses to these proteins. A heterogeneous cluster included the
6 h and 12 h time points for most models, likely as a result of the small
number of differentially abundant proteins detected at these time
points. Application of t-SNE dimensionality reduction to capture clus-
tering patterns confirmed the existence of strain-specific responses
(Supplementary Figure 2). Similarly, we detected no common phos-
phorylation patterns, and differential phosphorylation events showed
minimal overlap (Supplementary Figure 1).
To evaluate whether any common response could be identified be-
tween pairs of differently stimulated yeast strains, we performed a
pairwise comparison of proteome (Fig. 2, panel c) and phosphopro-
teome signatures (Fig. S2) across the different models. At the protein
level we detected little intersection among sets of regulated proteins
from the different APP-expressing cells. The GFP model consistently
showed the lowest number of common deregulated proteins compared
to strains expressing APPs (Fig. 2, panel c). Only a small set of proteins
changed their abundance in response to all APPs but not GFP; we term
this the “aggregation signature” (Fig. 2, panel c). Among proteins from
this group, we detected an overall up-regulation of Ret3p, which
mediates the retrograde transport from the ER to the Golgi apparatus,
and Ymr295cp, a protein of unknown function. The remaining 11
proteins showed divergent expression profiles in the five APP models.
Notably, Ssa3p, which regulates protein folding and aggregation, was
up-regulated in Aβ42, FUS, and HTT models but down-regulated in the
TDP43- and αSyn-expressing strains. The Ctt1p cytosolic catalase was
affected in all the models at multiple time points, suggesting a role of
the oxidative stress response in APP-mediated toxicity. We detected 16
proteins that significantly changed in abundance in at least one time
point upon expression of all exogenous proteins including GFP. We term
this set the “overexpression signature” (Fig. 2, panel c). Within this set,
several proteins from amino acid metabolism pathways (His4p, His5p,
Arg1p, Gcv2p) showed a consistent down-regulation, whereas gluco-
neogenic enzymes Tdh3p and Mdh2 were consistently up-regulated.
We next focused on molecular chaperones, a class of proteins known
to be induced in response to protein aggregation. In cells subjected to
heat shock, we detected a pronounced up-regulation of various cha-
perone proteins (as defined by Gong et al. [38]) from different cellular
locations (Fig. 2, panel d), in line with previous reports and with the
known roles of these proteins in the response to proteotoxicity [32,33].
Eleven out of 15 chaperone proteins changed abundance in the heat-
shocked strains and in one or multiple APP models, revealing the ac-
tivation of chaperone-mediated pathways in all cases of exogenous
expression. Interestingly, APP-specific chaperone patterns were de-
tected (Fig. 2, panel d). In the Aβ42 model, we observed induction of
ER-resident Hsp70 and Hsp40 chaperones, known to be involved in the
translocation and folding of proteins in the ER and in the ER-associated
degradation pathway (Fig. 3); this may reflect the fact that the Aβ42 is
fused to an ER-targeting sequence in this model [24]. Expression of
αSyn resulted in the depletion of various cytosolic chaperones relative
to the control and in a slight induction of a mitochondrial and of an ER-
associated chaperone. In the FUS and TDP43 models we observed an
induction of a specific set of cytosolic chaperones and the depletion of
specific mitochondrial and other chaperones. Expression of HTT in-
duced complex chaperone alterations involving induction and depletion
events. These results indicate that inclusion formation by the different
APPs results in APP-specific cellular responses, including chaperone
responses.
2.4. APPs induce regulation of different biological processes
To gain insights into pathways and biological processes activated by
expression of the different APPs, we performed a functional enrichment
analysis on the set of proteins significantly changed in abundance or
phosphorylation status in the different proteotoxicity models. Amino
acid metabolic pathways were found enriched in all APP-expressing
strains and the GFP-expressing strain (Table 4).
The cellular response to αSyn expression involved mitochondrial
respiration, ER homeostasis, and eisosome complexes at the plasma
membrane (Fig. 2, panel b and Table 4). The expression of the RNA/
DNA-binding protein FUS led to alterations in gene expression regula-
tion, chromatin organization, and RNA processing and transport.
mRNA-binding proteins were also significantly enriched upon FUS ex-
pression Similarly, in the TDP43 model we identified an enrichment in
proteins from the biosynthesis pathways of RNA binding proteins
(Fig. 2, panel b and Table 4). Proteins from the mitochondrial protein
biosynthesis process were enriched in both FUS and TDP43 expressing
strains. Functional categories overrepresented in the HTT model were
the DNA repair category and several processes associated with synthesis
of nucleotides.
In the Aβ42-expressing strain we detected an enrichment in proteins
involved in the unfolded protein response, including several chaperones
known to localize to the ER (Lhs1p, Kar2p, Scj1p), and ER-associated
proteins involved in disulfide bond formation (Mpd1p, Pdi1p, Ero1p,
Eug1p), glycosylation (Pmt1p, Ktr1p, and Mcd4), and translocation
(Sil1p and Sec72p) (Fig. 3 and Table 2). Proteins involved in ER-asso-
ciated degradation, ER-to-Golgi trafficking (Erp1/2p, Erv46p, Bos1p),
and lipid/inositol metabolism (Dfr1p, Acb1p, Rib1p, Scs3p) were also
significantly enriched in the Aβ42 strain compared to the control
(Table 2), suggesting an overall involvement of the ER in the response
to aggregation of Aβ42 in the context of this yeast model in which Aβ42
is directly fused to an ER-targeting sequence [24]. In the Aβ42-ex-
pressing strain, we also detected enrichment in proteins from the re-
active oxygen species metabolic process, the pentose-phosphate shunt,
glyceraldehyde-3-phosphate metabolic processes and NADP metabolic
process, indicating alterations in central carbon metabolism.
Next, we predicted the set of kinases involved in the responses to
different APPs. We inferred kinase–substrate interactions from the
phosphorylation dataset, integrating consensus motif analysis and
context modelling using the NetworKIN algorithm [39]. Few phos-
phosites were affected in more than one condition (Fig. 4, orange and
red nodes). In contrast, we identified several kinases as involved in
multiple APP models (Fig. 4, gray nodes). Among these were Cka1 (for
which we found an enrichment based on several sites in FUS-, Aβ42-,
αSyn-, and HTT-expressing cells), Pkc1 (enriched in strains expressing
FUS, Aβ42, and αSyn), and Pho85 (enriched in strains expressing FUS,
HTT, and Aβ42) (Table 5).
Taken together, these results indicate that yeast cells have complex
responses to the different APPs. Only a few cellular processes, mainly
involving metabolic functions, were activated in common, in the dif-
ferent APP expression models. Phosphoproteomic investigation con-
firmed the existence of APP-specific cellular responses but kinase en-
richment analysis also revealed some common regulatory mechanisms
activated upon over-expression of different amyloidogenic proteins.
2.5. APPs primarily affect the subcellular location where inclusions form
In our functional enrichment analyses, we noticed that expression of
the different APPs affected biological processes connected to the sub-
cellular locations where inclusion formation occurs. αSyn forms inclu-
sions that are initially located at the plasma membrane and that
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subsequently move to the cytoplasm. In keeping with this, we observe
enrichment of eisosome complexes among proteins that change in yeast
expressing αSyn; these plasma membrane complexes are known to act
as sensors of membrane stress [40] and our observations are therefore
consistent with perturbation of the plasma membrane in these strains.
Similarly, the Aβ42 peptide forms inclusions in the ER, and we observe
an enrichment of ER-specific responses in this model. TDP43 and FUS
inclusions co-localize with cytoplasmic ribonucleoprotein bodies, re-
flected by our observation of altered RNA processing and transport
processes and enrichment of mRNA-binding proteins in the response to
TDP43 and FUS expression. The one exception to this pattern was the
HTT model; HTT inclusions are cytoplasmically located, but we did not
observe the activation of specific cytosolic pathways in our enrichment
analysis. These observations suggest that the response to the aggrega-
tion of the different APPs is driven by the subcellular location where
inclusions form.
Indeed, when we extended the GO enrichment analysis to the cel-
lular component term, we observed similar associations. In this ana-
lysis, we converted the resulting list of enriched categories to a Boolean
matrix of 175 elements and clustered them to detect common regula-
tion patterns (Fig. 2, panel b). Again, we detected strain-specific pat-
terns of enrichment. In addition, enriched cellular components for a
particular strain again tended to match the subcellular location of in-
clusions in that strain. The ER was exclusively enriched in Aβ42-ex-
pressing yeast. In the αSyn model, we found a specific enrichment in
proteins from mitochondria, plasma membrane, and eisosomes. We
observed an enrichment of nuclear proteins (where aggregation of FUS
and TDP43 initially takes place [30,41]) in TDP43- and FUS-expressing
cells (Fig. 2, panel b), with proteins involved in proton transport
connected to ATP synthesis additionally enriched in the TDP43 model.
Proteins associated with the acetyltransferase SAGA, transcription
factor TFIID, and RNA polymerase complexes were enriched in the FUS
model (Fig. 2, panel b), recapitulating the physiological role of the
protein in RNA metabolism and transcription regulation. In the HTT
model we only observed an enrichment in mitochondria-associated
proteins, which was common to most strains. GFP expression resulted
only in enrichment in nucleolar proteins.
These data suggest the hypothesis that the cellular responses to the
different APPs involve interactions with molecular players at the loca-
tion of the inclusions. To evaluate this, we sought to identify interaction
partners of three different APPs. Using an antibody against the GFP tag,
we immunoprecipitated GFP-αSyn, GFP-HTT, and GFP-TDP43 and
analysed immunoprecipitates by mass spectrometry after three and six
hours of induction of APP expression. The GFP strain was used as
control to identify nonspecific interactions (see Material and Methods
for details). We identified nine, 61, and 85 interactors for αSyn, HTT,
and TDP43, respectively (Table 6) with most proteins detected at both
time points. Several proteins involved in RNA processing were found
associated to TDP43, supporting our hypothesis. In the αSyn im-
munoprecipitate, we did not identify any proteins known to localize to
the plasma membrane, possibly due to the removal of membrane debris
from the cell lysate during protein extraction. Cytosolic chaperone
proteins, as well as several proteins involved in protein targeting and
export and cytoskeleton organization, were associated with HTT.
Several chaperones were identified in the APP immunoprecipitates;
Ssc1p, Ssa3/4p, Kar2p, Hsp82p, and Hsp104p associated with at least
two APPs. In contrast, Sse1p and Sse2p were uniquely associated with
αSyn; Hsc82p, Ydj1p, Pdi1p, Cct8p, and Mdj1p associated only with
Fig. 3. Protein abundance variations in the protein folding and secretion pathway in the Aβ42 model. Key proteins of the ER secretion pathway are shown. Red nodes
represent upregulated proteins while gray nodes represent proteins not changing abundance in the Aβ42 model compared to the control. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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TDP43; and Hsp60p immunoprecipitated only with HTT (Fig. 5, panel
a). These data support the existence of APP-specific chaperone re-
sponses; whether location-specific physical interactions drive the re-
sponse to APP expression will need further confirmation.
2.6. Protective and toxic events in yeast expressing APPs
Proteome changes detected in our screen in response to the different
APPs may reflect the activation of protective cellular responses or
biological processes involved in toxicity of the APP. To differentiate
between protective and toxic proteome responses we used information
from previous genome-wide genetic screens conducted in the same APP
yeast models. These screens identified sets of genes that suppressed or
enhanced the toxicity of the respective APP and could play a role in the
respective protein aggregation disease [19], [24,42–45]. We reasoned
that toxicity suppressors up-regulated or toxicity enhancers down-
regulated in our proteomic screens may be involved in processes
counteracting the proteotoxic insult. Similarly, the downregulation of
suppressors and the upregulation of enhancers may be involved in
mechanisms that result in toxicity and ultimately death of yeast cells.
A total of 47 known genetic modifiers of the APPs were found to be
differentially abundant in our proteomic analysis. We classified as
protective those proteins that were up-regulated in our proteomics
analysis that inhibited APP toxicity when the gene was ablated in the
previous genetic screen, or that were down-regulated in our analysis
and enhanced APP toxicity in the genetic screen. Similarly, we defined
Fig. 4. Changes in phosphorylation in response to APP expression. The coloured nodes in the network show changing phosphosites for all strains. Yellow nodes
indicate phosphorylation sites that change in a single strain, orange and red nodes show sites changing in more than one strain, as reported in the legend. Gray nodes
show the kinases predicted to be involved in the detected phosphorylation events. Size of the gray nodes is proportional to the number of APP strains in which the
kinase was predicted, as reported in the legend. Edges represent protein-protein and genetic interactions between proteins bearing the p-sites and/or the predicted
kinase. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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as toxic those proteins that were significantly down-regulated in our
proteomics dataset and previously annotated as enhancers or that were
up-regulated and shown to be suppressors in the genetic screen. In total,
we defined 24 proteins as protective. We observed changes in
abundances of each of these proteins after 12 h of expression of the APP
(Fig. 5, panel b). Among protective proteins for the αSyn model are
proteins involved in ER-to-Golgi trafficking (Bre5p, Ykt6p, Ypt1p), re-
sponse to oxidative stress (Sod2p), and RNA processing (Stb3p and
Fig. 5. Genetic and physical interactions with APPs. (a) The networks depict physical interactors of the indicated APPs, colour coded according to their GO
annotation. (b) The heat maps show abundance changes over time for proteins previously annotated as genetic interactors of the indicated APP. Proteins are classified
as protective or toxic depending on the direction of the abundance change and the nature of the genetic interaction.
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Hbs1p), and the ER chaperones Eps1. In the FUS model, the protective
kinase Rim15 was associated with the phosphorylation of Adr1p and
Ssn2p; the latter factors are involved in the regulation of transcription.
The proteins protective in the αSyn model were all upregulated upon
αSyn expression. The kinase Pbs2p of the HOG signalling pathway is
the only protein we classified as protective in the Aβ42 strain; it was
upregulated upon Aβ42 expression. We classified the down-regulation
of the RNA-binding protein Sro9p, from early to late time points, as
protective for cells expressing TDP43. Finally, the up-regulation of
Glo2p, Rrf1p, and Gda1p was protective for HTT-expressing cells. In
total, we categorized 23 proteins as toxic. These are mainly associated
with mitochondria or RNA-related processes in the FUS model, with
osmotic stress in the HTT model, and with lipid signalling and cell
metabolism in the αSyn model.
3. Discussion
Protein folding is crucially important to life. When globular proteins
fail to adopt a functional fold they can assemble into aberrant ag-
gregates, which accumulate intracellularly and have been linked to
cellular dysfunction. Protein conformational disease, however, also
involves proteins that do not adopt a stable globular fold. In particular,
intrinsically disordered proteins/regions (IDP/IDR) are over-re-
presented among disease-associated proteins, with disorder being
linked both to normal function as well as to aberrant function in dis-
ease; this has led to the proposal of the ‘disorder in disorders’ (D2)
concept of human disease [46]. All of the proteins in our study fall into
this category: they are either IDPs (αSyn and Aβ42), or hybrid proteins
including IDRs (FUS, HTT, and TDP43). Many IDPs form aggregates of
amyloid nature, which have been associated with human neurodegen-
erative disorders such as Parkinson's or Alzheimer's disease. The amy-
loid fold is highly conserved in terms of structure and physico-chemical
properties, irrespective of the sequence of the protein involved. Neu-
rodegenerative diseases involving aggregates from different proteins
are however characterized by drastically different clinical phenotypes
and progression patterns. This may be because aggregates affect dif-
ferent cell types or brain regions in different diseases, as has been
shown for some of these pathologies. It is also possible that aggregates
of different APPs elicit different cellular responses. Although many
studies have addressed the molecular mechanisms underlying APP-in-
duced cytotoxicity, there has been no systematic, global comparison of
the cellular responses to different disease-related APPs. Further, it is
unclear whether cellular responses to aggregates of a single protein
resemble responses of cells to generalized intracellular protein ag-
gregation, as induced for example by an increase in temperature.
Taking advantage of a consistent set of well-characterized yeast
proteotoxicity models, we dissected cellular responses to the over-
expression of five human APPs and to generalized protein aggregation
induced by heat shock. We confirmed prior observations that expres-
sion of APPs causes intracellular inclusions and time-dependent toxi-
city, although different APPs impaired cell growth to different extents.
Proteomic and phosphoproteomic analyses revealed a progressive al-
teration in cellular homeostasis, via APP-specific responses that were
markedly different from the response to generalized temperature-in-
duced protein aggregation. Gene ontology enrichment analysis of al-
tered proteins and phosphorylation sites revealed substantial hetero-
geneity in the processes affected by the different APPs.
Interestingly, specific cellular responses to APPs largely involved
the subcellular compartment where inclusions of the APP accumulate.
The plasma membrane and membrane-associated eisosome complexes
were solely altered in the αSyn model, possibly reflecting a perturba-
tion of membrane architecture upon formation of early aSyn inclusions
[47]. Indeed, in the yeast model, α-Syn first localizes to the plasma
membrane or the cortical ER, which in yeast underlies the plasma
membrane α-Syn has also been reported to associate with lipid rafts and
caveolae, eukaryotic lipid domains that share similarities to eisosomes in
yeast and have been proposed to be analogous structures [48]. Through its
N-terminal lipid binding domain, α -Syn is thought to bind to a variety
of cellular membranes, including the plasma and mitochondrial mem-
branes [49]. Indeed, overexpression of α-Syn also affected mitochon-
drial respiration and ER homeostasis in our screen, consistent with
observations in mammalian models [50,51]. A direct interaction of
αSynuclein with mitochondria has been extensively reported [52–54]
and linked to disease progression [55].
In the FUS and TDP43 models we detected changes mainly in pro-
cesses connected to nuclear and RNA binding proteins, transcriptional
machineries, chromatin organization, RNA processing and transport.
Consistently, FUS and TDP43 are well-established DNA- and RNA-
binding proteins implicated in transcriptional regulation and RNA
splicing [56]. Despite their default nuclear localization, the two pro-
teins shuttle to the cytosol under stress or pathological conditions,
where they can bind stress granules and form inclusions [19,28]. The
enrichment that we see for RNA processing and mRNA-binding pro-
teins, as well as the cytoplasmic localization of FUS and TDP43 inclu-
sions, could reflect this association with stress granules. Indeed, the
66% of all RBPs we identified as enriched in the FUS model, half of
which have human orthologues, have been previously shown to localize
to stress granules or p-bodies under stress conditions [57]. We were also
able to detect a physical interaction of TDP43 with several yeast RNA-
binding proteins. Finally, the mitochondrial protein biosynthesis pro-
cess was also enriched in both FUS and TDP43 models, mirroring the
severe mitochondrial dysfunction in ALS pathogenesis [58].
In the Aβ42 model, we found an enrichment of ER-associated cha-
perones, genes involved in the unfolded protein responses, ER-asso-
ciated degradation, and ER-to-Golgi trafficking. Again, the involvement
of ER-associated processes in response to expression of Aβ42 is con-
sistent with our observation across models that the cellular response to
APP expression takes place at least in part at the location at which it
accumulates. In this case, the response likely reflects targeting of Aβ42
to the ER via fusion to a signal sequence and the formation of ER-as-
sociated Aβ42 oligomers in the yeast model [24]. We note that, phy-
siologically, Aβ42 is not directly targeted to the ER. The 30-fold in-
crease in expression of the transcription factor Hac1, together with the
enrichment in UPR-regulated genes, supports activation of the unfolded
protein response (UPR) likely to restore ER homeostasis after the per-
turbation induced by Aβ42 aggregation [59–61]. In addition, we
identified an enrichment in the oxidative stress response as well as in
the glycolysis and pentose shunt pathways, paralleling alterations in
brain metabolism seen in Alzheimer's disease patients [26,62,63]. In-
duction of an oxidative stress response by overexpression of Aβ42 is
further supported by the up-regulation, from early to late time points,
of the cytoplasmic antioxidant protein Tsa1, known to protect yeast
from the oxidative stress caused by misfolded or aggregated proteins.
Lastly, in the HTT model the enrichment we see for DNA repair and
synthesis of nucleotides processes could indicate DNA fragmentation,
previously associated with HTT toxicity together with the loss of nu-
clear envelope integrity [64].
The response of chaperone proteins to expression of the different
APPs also supports the notion that there is a link between subcellular
location of inclusions and that of the response. Chaperones clearly re-
sponded to APP expression in all aggregation models, but the response
was qualitatively and quantitatively different, depending on the ex-
pressed APP. We often observed changes for compartment-specific
chaperones associated with APPs that formed inclusions at the corre-
sponding subcellular location. For example, mainly ER-specific cha-
perones were up-regulated in the Aβ42 model, reflecting the ER loca-
lization of Aβ42 inclusions [24], while the TDP43 model, where
inclusions are formed in the cytosol, showed upregulation of mainly
cytosolic chaperones. In the heat-shocked sample as well, mainly cy-
tosolic promiscuous chaperones were up-regulated, some of which also
responded to the overexpression of specific APPs.
Overall, our data suggest that cells specifically respond to the
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overexpression of the different APPs by activating biological pathways
associated with the subcellular compartment where protein inclusions
accumulate. Such responses could be triggered by local damages at the
aggregation site, sequestration of compartment-specific factors into the
aggregates or saturation of compartment-specific quality control sys-
tems. This in turn emphasizes the need to tailor therapeutic manip-
ulations aimed at boosting protein quality control to the subcellular
compartment affected by the aggregation process [65]. In addition, care
should be taken when designing research models to study intracellular
aggregation, since the cellular response depends markedly on the spe-
cific APP and the location of inclusions.
Common responses to different APPs mostly included functionally
unrelated proteins and proteins involved in the oxidative stress re-
sponse and ER-to-Golgi trafficking, while the general response to
overexpression mostly involved proteins involved in amino acid meta-
bolic pathways, possibly as a consequence of the energetic burden that
the production of a heterologous protein entails. In most models, the
fraction of downregulated proteins was higher than that of upregulated
proteins in response to APP expression, which we also observed in the
response to heat shock. This may indicate the activation of protein
degradation systems, such as autophagy, in response to protein ag-
gregation, or the trapping and precipitation of proteins in APP ag-
gregates.
Proteins that responded to the expression of different APPs should
reflect both toxicity pathways and protective responses that counteract
the proteotoxic insult. To discriminate between these two scenarios, we
cross-referenced our proteomics dataset with recently published lists of
genetic modifiers of APP toxicity and report putative components of
toxicity mechanisms or protective regulatory programs, which may be
followed up in future studies.
In conclusion, our systematic proteomic and phosphoproteomic
study provides global insight into the cellular effects of human disease-
associated APPs in yeast. Further work will be needed to determine if
the APP-specific responses we observe in these models, as well as the
intriguing link between location of inclusions and of cellular response,
also apply to human cells.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jprot.2020.103862.
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